A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis

Arthritis and Rheumatism

Volumn 56, Issue 2, 2007, Pages 521-530

  Onodera, Shin ^a   Ohshima, Shigeki ^a   Tohyama, Harukazu ^a   Yasuda, Kazunori ^a   Nishihira, Jun ^b   Iwakura, Yoichiro ^c   Matsuda, Ikkei ^d   Minami, Akio ^a   Koyama, Yoshikazu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GeneticLab Co   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; OLIGONUCLEOTIDE; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DNA IMMUNIZATION; DNA SEQUENCE; DRUG EFFECT; DRUG EFFICACY; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; JOINT DESTRUCTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYMPTOM;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CERCOPITHECUS AETHIOPS; COLLAGEN; COS CELLS; DISEASE MODELS, ANIMAL; DNA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTRAMOLECULAR OXIDOREDUCTASES; JOINTS; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; TETANUS TOXOID; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA;

EID: 33847084328     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22407     Document Type: Article

References (34)

1. Morand EF. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Intern Med J 2005;35:419-26.
2. Onodera S, Tanji H, Suzuki K, Kaneda K, Mizue Y, Sagawa A, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999;11:163-7.
3. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994;33:14144-55.
4. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor (MIF) up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000;275:444-50.
5. 2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001; 44:1273-80.
6. Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, Wolvetang E, et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 2003;48:1881-9.
7. Ichiyama H, Onodera S, Nishihira J, Ishibashi T, Nakayama T, Minami A, et al. Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 2004;26:187-94.
8. Morand EF, Leech M, Wedon H, Metz C, Bucala R, Smith MD. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology 2002;41:558-62.
9. Baugh JA, Chitnis S, Donnely SC, Monteiro J, Lin X, Plant BJ, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002;3:170-6.
10. Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathomechanism of collagen type-II induced arthritis in mice. J Immunol 1997;158:5514-7.
11. Leech M, Metz CN, Santos L, Peng T, Holdsworth SR, Bucala R, et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998;41:910-7.
12. Clark M. Antibody humanization: a case of the 'Emperor's new clothes'? Immunol Today 2000;21:397-402.
13. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 1998;187:1463-75.
14. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. .Gene 1991;108:193-200.
15. Panina-Bordignon P, Tan A, Termijtelen A, Demotz, Corradin G, Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 1989;19:2237-42.
16. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nature Biotech 1998;16:867-70.
17. Kobayashi S, Nishihira J, Watanabe S, Todo S. Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology 1999;29:1752-9.
18. Terato K, Harper DS, Griffiths MM, Hasty DL, Ye XJ, Cremer MA, et al. Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity 1995;22:137-47.
19. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000;191:313-20.
20. Suzuki M, Sugimoto H, Nakagawa A, Tanaka I, Nishihira J, Sakai M. Crystal structure of the macrophage migration inhibitory factor from rat liver. Nature Struct Biol 1996;3:259-66.
21. Spohn G, Schwarz K, Maurer P, Illges H, Rajasekaran N, Choi Y, et al. Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles. J Immunol 2005;175:621.1-8.
22. Brennan FM, Chantry D, Jackson A, Maim R, Feldmann M. Inhibitory effect of TNF α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-7.
23. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role. J Exp Med 1999;189:341-6.
24. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999;42:1601-8.
25. Onodera S, Nishihira J, Koyama Y, Majima T, Aoki Y, Ichiyama H, et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1β. Arthritis Rheum 2004;50:1437-47.
26. Horai R, Nakajima A, Habiro K, Kotani M, Nakae S, Matsuki T, et al. TNF-α is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. J Clin Invest 2004;114:1603-11.
27. Dalum I, Jensen MR, Hindersson P, Elsner HI, Mouritsen S. Breaking of B cell tolerance toward a highly conserved self protein. J Immunol 1996;157:4796-804.
28. Dalum I, Jensen MR, Gregorius K, Thomasen CM, Elsner HI, Mouritsen S. Induction of cross-reactive antibodies against a self protein containing a foreign T helper epitope. Mol Immunol 1997;34:1113-20.
29. Dalum I, Butler DM, Jensen MR, Hindersson P, Steinaa L, Waterston AM, et al. Therapeutic antibodies elicited by immunization against TNF-α. Nat Biotechnol 1999;17:666-9.
30. Donnelly JJ, Ulmer JB, Liu MA. DNA vaccines. Life Sci 1997;60:163-72.
31. Youssef S, Wildbaum G, Maor G, Lanir N, Gour-Lavie A, Grabie N, et al. Long-lasting protective immunity to experimental auto-immune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J Immunol 1998;161:3870-9.
32. Klinman DM, Currie D, Gursel I, Verthelyi D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 2004; 99:201-16.
33. Hertz M, Mahalingam S, Dalum I, Klysner S, Mattes J, Neisig A, et al. Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J Immunol 2001; 167:3792-9.
34. Selby M, Goldbeck C, Fertile T, Walsh R, Ulmer J. Enhancement of DNA vaccine potency by electroporation in vivo. J Biotechnol 2000;83:147-52.